Based on findings published in JAMA Network Open, screening patients for pancreatic cancer based solely on elevation in glycated hemoglobin (HbA1c) level is not likely to represent an effective approach.
Given this, researchers indicated that alternative approaches to risk stratification are still necessary for patients with pancreatic cancer to improve early detection. Read more . . .